To include your compound in the COVID-19 Resource Center, submit it here.

RVSV HIV-1 gag vaccine: Phase I started

Profectus began a double-blind, placebo-controlled, dose-escalation, Phase I trial to evaluate its

Read the full 128 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE